Intravitreal toxicity of bovine cartilage extract (Catrix-S) : a biologic response modifier
Miller, A.; Joondeph, B.; Peyman, G.A.; Fiscella, R.
Annals of Ophthalmology 20(3): 100
1988
ISSN/ISBN: 0003-4886 PMID: 3400952 Document Number: 308112
The intravitreal toxicity of Catrix, a biologic response modifier, was evaluated. A dose of up to 5 mg did not cause a toxic reaction in the ocular structures.
Document emailed within 1 workday
Related Documents
Elias, A.N.; Sharma, B.S.; Valenta, L.J.; Kyaw, T. 1988: Immunomodulatory effect of bovine PTH extract on lymphocyte response to plant mitogens Journal of Medicine 19(2): 109-117Brown, T.D. 1989: Biologic response modifiers: understanding biologic systems Texas Medicine 85(11): 4-5
Brown, T.D. 1989: Biologic response modifiers: understanding biologic systems Texas Medicine 85(11): 4-5
Nikoleit, J.R.; Peyman, G.A.; Lagouros, P.; Fiscella, R. 1988: Retinal toxicity of intravitreal ethyldeoxyuridine and zinc Annals of Ophthalmology 20(10): 385-387
Maillard, F. 1994: Pidotimod. A new biological response modifier. Introduction Arzneimittel-Forschung 44(12a): 1399-1401
Berman, B.; Poochareon, V.N.; Villa, A.M. 2002: Novel dermatologic uses of the immune response modifier imiquimod 5% cream Skin Therapy Letter 7(9): 1-6
Majima, H.; Nomura, K. 1986: Phase i clinical study of MY-1, a new biological response modifier Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(1): 109-115
Tyring, S. 2001: Imiquimod applied topically: A novel immune response modifier Skin Therapy Letter 6(6): 1-4
Reiman, V.; Bujia, J.; Pitzke, P.; Hochstrasser, K.; Kastenbauer, E. 1990: MR-spectroscopic evaluation of the biologic suitability of cartilage transplants Biomedizinische Technik. Biomedical Engineering 35(Suppl 3): 252-253
Matsunaga, K.; Morita, I.; Oguchi, Y.; Fujii, T.; Yoshikumi, C.; Nomoto, K. 1987: The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice Anticancer Research 7(3 Part B): 509-512
McGuire, T.C.; Musoke, A.J. 1981: Biologic activities of bovine IgG subclasses Advances in Experimental Medicine and Biology 137: 359-366
Hunziker, E.B. 1999: Biologic repair of articular cartilage. Defect models in experimental animals and matrix requirements Clinical Orthopaedics and Related Research 1999(367(Suppl): S135-S146
Dvorchik, B.H.; Marquis, J.K. 2000: Disposition and toxicity of a mixed backbone antisense oligonucleotide, targeted against human cytomegalovirus, after intravitreal injection of escalating single doses in the rabbit Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(10): 1255-1261
Bhurayanontachai, P.; Ratanasukon, M.; Ma-a-lee, A. 2009: The response pattern of intravitreal triamcinolone injection for non-AMD macular edema Journal of the Medical Association of Thailand 92(1): 58-63
Braun, R.K.; Osburn, B.I.; Kendrick, J.W. 1973: Immunologic response of bovine fetus to bovine viral diarrhea virus American Journal of Veterinary Research 34(9): 1127-1132
Bhave, M.; Akhter, N.; Rosen, S.T. 2014: Cardiovascular toxicity of biologic agents for cancer therapy Oncology 28(6): 482-490
Ebina, T. 2012: Hepatic intra-arterial infusion of biological response modifier (BRM)-activated killer immune lymphocytes to treat liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 1812-1814
Moav, N.; Harris, T.N. 1970: Biologic activities of lymph node cells fractionated on bovine plasma albumin Journal of Immunology 105(6): 1512-1521
Camacho, F.; Elorza, F.L.; Ortega, M.; Elorza, M.A.; Sada, G.; Villarrubia, V.G. 1991: AM3 (a biological response modifier) in the treatment of recurrent aphthous stomatitis. Clinical evaluation and preliminary studies on NK (CD16) cells and their pathogenic role in the syndrome Revista Clinica Espanola 188(8): 403-408
Salter, D.M.; Nuki, G.; Wright, M.O. 1996: IL-4 inhibition of cartilage breakdown in bovine articular explants Journal of Rheumatology 23(7): 1314-1315